Exploring the Role of Targeted Therapies in Treating Bone Metastases
Received Date: Oct 01, 2024 / Published Date: Oct 29, 2024
Abstract
Bone metastases, where cancer cells spread to the bone from a primary tumor, present significant challenges in oncology, including pain, fractures, and a reduced quality of life. Traditional treatments often involve systemic therapies, radiation, and surgery, but targeted therapies have emerged as a transformative approach in managing bone metastases. This article explores the role of targeted therapies in treating bone metastases, focusing on their mechanisms, types, benefits, and challenges. Targeted therapies, including bisphosphonates, denosumab, and radiopharmaceuticals, offer precision in addressing bone resorption and tumor growth, aiming to reduce skeletalrelated events and enhance patient outcomes. The article also discusses ongoing research and future directions in this evolving field.
Citation: Jonathan D (2024) Exploring the Role of Targeted Therapies in Treating Bone Metastases. Cervical Cancer, 9: 235.
Copyright: © 2024 Jonathan D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Usage
- Total views: 60
- [From(publication date): 0-0 - Jan 10, 2025]
- Breakdown by view type
- HTML page views: 41
- PDF downloads: 19